‘Pharma Bro’ Company Vyera Settles Suit Over Drug Pricing (2)

Vyera Pharmaceuticals LLC, the company once led by convicted “Pharma Bro” Martin Shkreli, agreed to pay as much as $40 million to resolve a federal antitrust lawsuit over a 2015 drug-pricing scandal.

Under a settlement agreement, former Vyera Chief Executive Officer Kevin Mulleady will be barred “from almost any role at a pharmaceutical company for seven years,” Attorney General Letitia James, who led a group of states in the lawsuit, said in a statement Tuesday.

A joint motion outlining the deal was filed in federal court in Manhattan, where James and the U.S. Federal Trade Commission filed ...